Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 1/20 | 0.32 |
| ▸ | PIM1 | P11309 | 2/20 | 0.31 |
| ▸ | PIM3 | Q86V86 | 2/20 | 0.31 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19162792 | 0.94 | PIK3CA (0.34) | PIK3CAHRH4 | |
| SCHEMBL19161774 | 0.94 | PIK3CA (0.32) | PIK3CAHRH4 | |
| SCHEMBL19161905 | 0.93 | PIK3CA (0.33) | LIMK1PIM1PIM3PIM2PIK3CA | |
| SCHEMBL19161445 | 0.93 | PIK3CA (0.33) | LIMK1PIM1PIM3PIM2PIK3CA | |
| SCHEMBL19161308 | 0.93 | PIK3CA (0.35) | PIK3CAHRH4 | |
| SCHEMBL19163160 | 0.92 | PIK3CA (0.33) | PIK3CAHRH4 | |
| SCHEMBL19163194 | 0.91 | PIK3CA (0.33) | PIK3CAHRH4 | |
| SCHEMBL19161374 | 0.91 | PIK3CA (0.33) | LIMK1PIM1PIM3PIM2PIK3CA | |
| SCHEMBL19162922 | 0.91 | PIK3CA (0.33) | LIMK1PIM1PIM3PIM2PIK3CA | |
| SCHEMBL19162622 | 0.90 | HRH4 (0.30) | LIMK1HRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10347845-B2 | Nitrogen-containing condensed cyclic compound and organic light emitting device using same | LG CHEM, LTD. (KR) | 2019-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10347845-B2 | Nitrogen-containing condensed cyclic compound and organic light emitting device using same | CRY1, NOS1, NOLC1 | LIMK1 1200/4885PIM1 2683/4885PIM3 4309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.